Military to Screen All Members Over 30 for Testosterone Levels
3 verified3 unconfirmed
Defense Secretary Pete Hegseth announced this week that the U.S. military will require all active duty and reserve personnel aged 30 and older to undergo mandatory testosterone-level screening during annual physicals. In a social media video, Hegseth said the program aims to “restore and optimize” natural capabilities and protect longevity, adding it is not about artificial enhancement. The Endocrine Society responded with a statement noting there is insufficient evidence to support routine, population-level screening for testosterone deficiency in asymptomatic men. Both sources report that military members under 30 can also request screening, though this detail appears in only one account. The announcement is the latest in a series of health-related policy changes under Hegseth’s leadership, including earlier moves to end mandatory flu and COVID-19 vaccine mandates for service members. Medical experts quoted in the reports emphasize that testosterone levels naturally decline with age and that low T can sometimes signal underlying conditions better addressed by other treatments.
What’s verified
Defense Secretary Pete Hegseth announced mandatory testosterone screening for all active duty and reserve personnel aged 30 and older during annual physicals.
Hegseth stated the initiative is about “restoring and optimizing” natural capabilities, not artificial enhancement.
The Endocrine Society stated there is insufficient evidence to support population-level screening for testosterone deficiency in asymptomatic individuals.
Not yet confirmed
Whether service members under 30 can request screening (reported in one source).
The claim that only 12% of men currently receiving testosterone prescriptions had appropriate diagnostic testing (reported in one source).
Details about Hegseth’s other policy moves, such as rebranding the Department of Defense or changing vaccine requirements, are mentioned in only one source and not corroborated.
Misconceptions
Both sources address the misconception that widespread testosterone screening and treatment is beneficial for asymptomatic individuals, citing the Endocrine Society’s finding of insufficient clinical evidence.
Key figures
Pete Hegseth, Defense Secretary
Endocrine Society (professional medical organization)
Professor Bradley Anawalt, chief of medicine, University of Washington Medical Center (quoted in one source)
Sources: Ars Technica, vox.com
